Retrieve available abstracts of 265 articles: HTML format
Single Articles
July 2025
WALIANY S, Hung YP, Rous FA, Luo F, et al Lung Carcinoid Tumors With Potentially Actionable Genomic Alterations and
Responses to Targeted Therapies.
Clin Lung Cancer. 2025;26:354-363. PubMedAbstract available
June 2025
CAI OY, Fernandez JR, Aldrich MC, Richmond J, et al Assessing Factors Associated With Patient-Provider Discussions About Lung Cancer
Screening Using Andersen's Behavioral Model of Health Services Utilization.
Clin Lung Cancer. 2025 Jun 12:S1525-7304(25)00136. PubMedAbstract available
SAKATA Y, Saito G, Sakata S, Yamaguchi T, et al Osimertinib as First-Line Treatment for Patients With Advanced EGFR
Mutation-Positive Non-Small Cell Lung Cancer in a Real-World Setting: Updated
Overall Survival Data (OSI-FACT-OS).
Clin Lung Cancer. 2025 Jun 10:S1525-7304(25)00129. PubMedAbstract available
ROBINSON SD, Wong CD, Mazarakis NK, Lorimer C, et al A Review of Focal Therapies for Small Cell Lung Cancer Brain Metastases.
Clin Lung Cancer. 2025 Jun 10:S1525-7304(25)00132. PubMedAbstract available
BAZHENOVA L, Hodgson JG, Camidge DR, Langer CJ, et al Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive
Non-Small-Cell Lung Cancer According to ALK Fusion and Mutation Status.
Clin Lung Cancer. 2025 Jun 6:S1525-7304(25)00128. PubMedAbstract available
HENRIKSEN MB, Hilberg O, Juul C, Thomsen R, et al Maximizing Lung Cancer Screening in High-Risk Population Leveraging ML-Developed
Risk-Prediction Algorithms: Danish Retrospective Validation of LungFlag.
Clin Lung Cancer. 2025 Jun 4:S1525-7304(25)00130. PubMedAbstract available
AHN JH, Choi SH, Park SH, Kim I, et al Longitudinal Analysis of Recurrence and Risk Factors of Early-Stage Resected
Adenocarcinoma With Common EGFR Mutations: A Multicenter Retrospective Cohort
Study in South Korea.
Clin Lung Cancer. 2025;26:314-323. PubMedAbstract available
CORRE R, Decroisette C, Auliac JB, Falchero L, et al First-Line Pembrolizumab Efficacy in Octogenarians With NSCLCs Expressing >/= 50%
PD-L1 (ESCKEYP GFPC 05-2018).
Clin Lung Cancer. 2025;26:331-337. PubMedAbstract available
GUTTA R, Teslow E, Jaeger E, Stoppler MC, et al Racial Diversity and Co-Mutational Analysis of Biologically Relevant Alterations
in EGFR Mutant Lung Cancers.
Clin Lung Cancer. 2025;26:307-313. PubMedAbstract available
LU C, Yan HH, Zhang CY, Chen SY, et al PEARL: A Multicenter Phase 2 Study of Lorlatinib in Patients with ALK-Rearranged
NSCLC and Central Nervous System Disease.
Clin Lung Cancer. 2025;26:263-266. PubMedAbstract available
May 2025
KRUITHOF PD, Brouns AJWM, Degens JHRJ, Hendriks LEL, et al Osimertinib Dose Optimization Guided by Therapeutic Drug Monitoring in Patients
With EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Case series.
Clin Lung Cancer. 2025 May 29:S1525-7304(25)00125. PubMed
KOSTER KL, Yohasenan S, Pakmak AS, Mark M, et al Predictors of Multidisciplinary Tumor Board Adherence in Stage III Non-Small-Cell
Lung Cancer Patients From a Large Multicenter Study.
Clin Lung Cancer. 2025 May 29:S1525-7304(25)00124. PubMedAbstract available
LIN JX, Zhou Q, Yan HH, Liu AW, et al A Patient-Centric, Open-Label, Multicenter, Phase II Study of Lorlatinib
Monotherapy in the First-Line Treatment of Patients With locally Advanced or
Metastatic ALK-Positive Non-Small Cell Lung Cancer (CTONG2203).
Clin Lung Cancer. 2025 May 28:S1525-7304(25)00127. PubMedAbstract available
PERUZZO N, Lenz G, Akhiwu T, Bilalaga M, et al Chemotherapy Plus Anti-PD-1 or Anti-PD-L1 in Advanced PD-L1-Negative Squamous
Cell Lung Carcinoma: A Systematic Review and Meta-Analysis.
Clin Lung Cancer. 2025 May 22:S1525-7304(25)00076. PubMedAbstract available
RAKEDZON S, Mor E, Yechiel Y, Saiet Y, et al Correlation of PET-CT, Endobronchial Ultrasound Cytology and Surgical Biopsy in
Patients with Non-Small Cell Lung Cancer Undergoing Curative Surgery.
Clin Lung Cancer. 2025 May 18:S1525-7304(25)00103. PubMedAbstract available
GWIN ME, Prasad T, Wahid U, Bhalla S, et al Mortality in a Diverse, Real-World Lung Cancer Screening Cohort.
Clin Lung Cancer. 2025 May 13:S1525-7304(25)00102. PubMedAbstract available
WATANABE Y, Koide Y, Shimizu H, Aoyama T, et al Combined Impact of Coronary Artery Calcification and Heart Radiation Dose on
Overall Survival in Locally Advanced Non-Small Cell Lung Cancer: Who Benefits
Most from Reducing Heart Radiation Dose?
Clin Lung Cancer. 2025 May 12:S1525-7304(25)00100. PubMedAbstract available
RIOS-GARCIA E, Guijosa A, Caballe-Perez E, Davila-Dupont D, et al Elucidating the Role of EGFR(L858R) in Brain Metastasis Among Patients With
Advanced NSCLC Undergoing TKI Therapy.
Clin Lung Cancer. 2025;26:e199-e206. PubMedAbstract available
SOLIMAN MM, Gershon B, Ra DS, Escalon JG, et al Imaging Findings Related to Lung Tract Sealant Use in Percutaneous CT-guided Lung
Biopsy.
Clin Lung Cancer. 2025;26:236-243. PubMedAbstract available
TAJE R, Ambrogi V, Tacconi F, Gallina FT, et al Kirsten Rat Sarcoma Virus Mutations Effect On Tumor Doubling Time And Prognosis
Of Solid Dominant Stage I Lung Adenocarcinoma.
Clin Lung Cancer. 2025;26:210-220. PubMedAbstract available
TAKAMORI S, Endo M, Hamada A, Ohara S, et al Prognostic Analysis of Pathological Stage I Lung Adenocarcinoma Harboring Major
EGFR Mutations.
Clin Lung Cancer. 2025;26:e172-e180. PubMedAbstract available
BRUNELLI A, Hoffman R, Wotton R, Baijal S, et al Surgical and Pathological Results Following Neoadjuvant Nivolumab and
Platinum-Based Chemotherapy for Locally Advanced Resectable NSCLC: A Multicentre
Real-World Series From England.
Clin Lung Cancer. 2025;26:253-261. PubMedAbstract available
PHAM D, Park JA, Wang H, Subramanian M, et al Computer Assisted Nodule Analysis and Risk Yield is Associated With Occult Lymph
Node Status in Clinical Stage I-IIA Lung Adenocarcinoma Undergoing Resection.
Clin Lung Cancer. 2025;26:e142-e149. PubMedAbstract available
April 2025
JOSEPHIDES E, Daddi N, Bertoglio P, Lugaresi M, et al A Propensity-Matched Comparison Between Minimally Invasive Surgery and
Stereotactic Radiotherapy in the Treatment of Clinical Stage IA Non-Small-Cell
Lung Cancer (NSCLC).
Clin Lung Cancer. 2025 Apr 29:S1525-7304(25)00083. PubMedAbstract available
PALECKI J, Tucker M, Bernstein A, Melby G, et al Multiple Sclerosis and Lung Cancer: A Single Cancer Center Experience in
Philadelphia.
Clin Lung Cancer. 2025 Apr 28:S1525-7304(25)00086. PubMedAbstract available
OHAEGBULAM K, Anderson C, Thompson RF, Mitin T, et al Common Medical Comorbidities Influence Pneumonitis Risk After Chemoradiotherapy
and Durvalumab Maintenance in Stage III Non-small Cell Lung Cancer.
Clin Lung Cancer. 2025 Apr 24:S1525-7304(25)00082. PubMedAbstract available
WEI L, Lao Y, Fu T, Xie Z, et al Distinct Role of TP53 Co-mutations in Different EGFR Subtypes Mediating the
Response to EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
Clin Lung Cancer. 2025 Apr 23:S1525-7304(25)00078. PubMedAbstract available
TOPKAN E, Ozturk D, Selek U Comment on: Association of Sarcopenia with Toxicity and Survival in Patients With
Lung Cancer, a Multi-Institutional Study With External Dataset Validation.
Clin Lung Cancer. 2025 Apr 14:S1525-7304(25)00075. PubMed
ODWUOR A, Lee P, Chang JY, Gandhi S, et al Outcomes and Toxicity following 3 or More Definitive Courses of Thoracic
Radiation Therapy for Non-Small Cell Lung Cancer.
Clin Lung Cancer. 2025 Apr 10:S1525-7304(25)00060. PubMedAbstract available
MA R, Yang H, Ge Y, Ma T, et al Prognostic Implications of Lymph Node Status in Non-Small-Cell Lung Cancer
Patients Before and After Neoadjuvant Chemoimmunotherapy: A Multicenter
Retrospective Study.
Clin Lung Cancer. 2025 Apr 8:S1525-7304(25)00062. PubMedAbstract available
LEE YG, Seo D, Gil HI, Lee H, et al Assessment of Lung Cancer Risks Related to Family History in Never-Smokers: A
Cohort Study.
Clin Lung Cancer. 2025 Apr 8:S1525-7304(25)00061. PubMedAbstract available
PINARD L, Ullur AR, Everest L, Zhan LJ, et al Real-World Creatinine-Based Estimates of Acute and Chronic Kidney Dysfunction in
Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Receiving
Tyrosine Kinase Inhibitors.
Clin Lung Cancer. 2025 Apr 8:S1525-7304(25)00059. PubMedAbstract available
March 2025
OH MS, Garon EB, Lisberg AE, Cummings AL, et al Brief Report: The Genomic Landscape of Small Cell Lung Cancer in Never-Smoking
Patients.
Clin Lung Cancer. 2025 Mar 31:S1525-7304(25)00057. PubMedAbstract available
KICKEN MP, Heine RT, Azarfane I, de Rouw N, et al The Toxicity Profile of Pemetrexed in Non-Small Cell Lung Cancer Patients With
Moderate Renal Impairment: A Retrospective Cohort Study.
Clin Lung Cancer. 2025 Mar 26:S1525-7304(25)00056. PubMedAbstract available
BOLTE FJ, Dougherty SC, Danos AO, Lynch AC, et al Real-World Outcomes of Tarlatamab in Small Cell Lung Cancer, Including Patients
With Untreated Brain Metastases.
Clin Lung Cancer. 2025 Mar 26:S1525-7304(25)00052. PubMedAbstract available
CHANG LC, Hu HW, Hsieh MS, Wu SG, et al Brief Report: The Effectiveness of Osimertinib in Advanced Nonsmall Cell Lung
Cancer Harboring Various EGFR Exon 19 Mutation Variants.
Clin Lung Cancer. 2025 Mar 21:S1525-7304(25)00054. PubMed
SHARGALL Y, Vella ET, Del Giudice ME, Dennie C, et al Systematic Review for the Follow-up of Curatively Treated Patients With Lung
Cancer.
Clin Lung Cancer. 2025 Mar 19:S1525-7304(25)00049. PubMedAbstract available
ELKEFI S, Phillips E, Groner LK, Matthews AK, et al Predictors of Up-To-Date Lung Cancer Screening Among Eligible People in the
United States: A Nationally Representative Dataset.
Clin Lung Cancer. 2025 Mar 17:S1525-7304(25)00051. PubMedAbstract available
CASTANEDA-GONZALEZ JP, Parra-Medina R, Riess JW, Gandara DR, et al Genetic Ancestry and Lung Cancer in Latin American Patients: A Crucial Step for
Understanding a Diverse Population.
Clin Lung Cancer. 2025 Mar 13:S1525-7304(25)00050. PubMedAbstract available
SARKARIA IS, Biro TG, Singhal S, Reddy RM, et al Intraoperative Molecular Imaging With Pafolacianine: Histologic Characteristics
of Identified Nodules.
Clin Lung Cancer. 2025;26:104-115. PubMedAbstract available
EVIN C, Razakamanantsoa L, Gardavaud F, Papillon L, et al Clinical, Dosimetric and Radiomic Features Predictive of Lung Toxicity After
(Chemo)Radiotherapy.
Clin Lung Cancer. 2025;26:93-103. PubMedAbstract available
STALKER M, Marmarelis M, Langer C, Cohen RB, et al Outcomes Following Treatment for Progression in Patients Treated With Durvalumab
Consolidation in LA-NSCLC.
Clin Lung Cancer. 2025;26:124-130. PubMedAbstract available
ZHOU Q, Li J, Cang SD, Lin JX, et al FLAIR: A Phase II, Open Label, Randomized Study of Osimertinib Plus Bevacizumab
Versus Osimertinib in Recurrent or Metastatic Treatment-Naive NSCLC Patients
Harboring EGFR 21L858R Mutation.
Clin Lung Cancer. 2025;26:152-157. PubMedAbstract available
PAZ-ARES L, Gupta B, Baena J, Liu SV, et al Unmet Needs in Maintenance Therapy for Extensive Stage Small Cell Lung Cancer.
Clin Lung Cancer. 2025 Mar 1:S1525-7304(25)00045. PubMedAbstract available
February 2025
MALIK PS, Pathak N, Sharma A, Birla M, et al Young Onset Lung Cancer in India: Insights Into Clinical, Demographic, and
Genomic Profiles.
Clin Lung Cancer. 2025 Feb 22:S1525-7304(25)00044. PubMedAbstract available
WALLACE ND, Xie J, Alexander M, Ball D, et al Completion Rates for Patients Undergoing Concurrent Chemoradiotherapy for Stage
III Nonsmall Cell Lung Cancer and its Importance in the Era of Consolidation
Immunotherapy: A Cohort Study.
Clin Lung Cancer. 2025 Feb 21:S1525-7304(25)00041. PubMedAbstract available
ZHANG Y, Zhou SH, Yan YJ, Wu LL, et al Predicting Severe Radiation Pneumonitis in Patients With Locally-Advanced
Non-Small-Cell Lung Cancer After Thoracic Radiotherapy: Development and
Validation of a Nomogram Based on the Clinical, Hematological, and Dose-Volume
Histogram Parameters.
Clin Lung Cancer. 2025 Feb 21:S1525-7304(25)00042. PubMedAbstract available
WILDER FG, McAllister M, Singh A, Xie Y, et al Lung Cancer in Patients Under 50: What is the Role of Social Determinants of
Health?
Clin Lung Cancer. 2025 Feb 20:S1525-7304(25)00039. PubMedAbstract available
KULKARNI R, Zeine E, Potugari B, Gadgeel S, et al Small Cell Lung Cancer With de novo BRAF V600E Mutation and Durable Response to
Targeted Therapy: A Case Report.
Clin Lung Cancer. 2025 Feb 20:S1525-7304(25)00040. PubMed
ROISMAN LC, Mann S, Basel A, Marei R, et al The PESGA Trial: A Prospective, Open-Label, Single-Arm, Phase II Study to
Evaluate First Line Therapy for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Patients, Treated by Induction Carboplatin/Etoposide/Pembrolizumab Followed by
Maintenance of Pe
Clin Lung Cancer. 2025 Feb 13:S1525-7304(25)00027. PubMedAbstract available
HE J, Liu Y, Wang X, Song R, et al The Impact of Radiation Dose to Immune Cells in Stage IV Non-Small Cell Lung
Cancer in the Era of Immunotherapy.
Clin Lung Cancer. 2025 Feb 13:S1525-7304(25)00036. PubMedAbstract available
SHAH M, Noronha V, Patil V, Singh AK, et al Genomic Profiling of Driver Gene Alterations in Patients With Non-Small Cell Lung
Cancer, Patterns of Treatment and Impact on Survival Outcomes: A Single Center
Experience of More Than 1200 Patients.
Clin Lung Cancer. 2025 Feb 11:S1525-7304(25)00026. PubMedAbstract available
TRISOLINI R, Cetoretta V, Sotgiu G, Cancellieri A, et al Supraclavicular Lymph Node Metastases in Advanced Lung Cancer: Prevalence and
Analysis of Demographic, Clinical and Molecular Characteristics.
Clin Lung Cancer. 2025 Feb 8:S1525-7304(25)00033. PubMedAbstract available
ALAPARTHI SS, Ho A, Rshaidat H, Whitehorn G, et al Outcomes of Segmentectomy With or Without Preoperative Biopsy in Non-Small Cell
Lung Cancer (NSCLC).
Clin Lung Cancer. 2025 Feb 8:S1525-7304(25)00034. PubMedAbstract available
BARRICHELLO APC, Elkrief A, Ricciuti B, Ganta T, et al Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With
Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High
(>/=50%) Patients.
Clin Lung Cancer. 2025 Feb 4:S1525-7304(25)00025. PubMedAbstract available
OKSEN D, Boutmy E, Wang Y, Stroh C, et al Patients With Advanced Non-small Cell Lung Cancer Harboring MET Alterations: A
Descriptive Cohort Study.
Clin Lung Cancer. 2025 Feb 1:S1525-7304(25)00024. PubMedAbstract available
January 2025
ZHU Z, Wu J, Zhao L, Jiang N, et al Induction Immunochemotherapy Followed by Hypo-Fractionated Radiotherapy in
Unresectable Stage III Non-Small Cell Lung Cancer.
Clin Lung Cancer. 2025 Jan 30:S1525-7304(25)00023. PubMedAbstract available
SARAF A, He J, Shin KY, Weiss J, et al Association of Sarcopenia With Toxicity and Survival in Patients With Lung
Cancer, a Multi-Institutional Study With External Dataset Validation.
Clin Lung Cancer. 2025 Jan 28:S1525-7304(25)00021. PubMedAbstract available
VERSCHUEREN MV, Hiensch DTA, Plomp PMJ, Kastelijn LA, et al Comparative Effectiveness of Nivolumab and Ipilimumab Plus Chemotherapy Versus
Pembrolizumab Plus Chemotherapy in PD-L1 Negative Metastatic Non-Small Cell Lung
Cancer Patients.
Clin Lung Cancer. 2025 Jan 25:S1525-7304(25)00009. PubMedAbstract available
PHILLIPS WJ, Jackson A, Kidane B, Lim G, et al Immunotherapy for Early-Stage Non-Small Cell Lung Cancer: A Practical Guide of
Current Controversies.
Clin Lung Cancer. 2025 Jan 15:S1525-7304(25)00006. PubMedAbstract available
JOSEPHIDES EC, Smith D, Bille A, Patel A, et al A Retrospective Evaluation of PD-L1 Expression and Heterogeneity in Early-Stage
Non-Small Cell Lung Cancer (REPLICA).
Clin Lung Cancer. 2025 Jan 13:S1525-7304(25)00008. PubMedAbstract available
WONG WKY, Mok KKS, Tsui GPC, Chen OH, et al CNS Outcomes of Osimertinib Plus Chemotherapy in Patients With EGFR Mutation
Positive Lung Cancer Beyond Osimertinib Progression.
Clin Lung Cancer. 2025 Jan 11:S1525-7304(25)00007. PubMedAbstract available
LARA MS, Riess JW, Kaleka G, Borowsky A, et al POLE Mutation Associated With Microsatellite Instability and High Tumor
Mutational Burden Confers Exquisite Sensitivity to Immune Checkpoint Inhibitor
Therapy in Non-Small Cell Lung Cancer: A Case Report and Genomic Database
Analysis.
Clin Lung Cancer. 2025 Jan 8:S1525-7304(25)00005. PubMed
HATA T, Yamada T, Goto Y, Amano A, et al Regimen Selection for Chemoimmunotherapy in Nonsquamous Non-Small Cell Lung
Cancer with Low PD-L1 Expression: A Multicenter Retrospective Cohort Study.
Clin Lung Cancer. 2025 Jan 4:S1525-7304(25)00001. PubMedAbstract available
GEEVARGHESE R, Petre EN, Ziv E, Santos E, et al Transarterial Embolization for the Management of Emergent Hemoptysis in Patients
With Primary and Metastatic Lung Tumors.
Clin Lung Cancer. 2025;26:45-51. PubMedAbstract available
HSIAO A, Woodward B, Ye P, Varga MG, et al Brief Report: Methylation-Based ctDNA Serial Monitoring Correlates With
Immunotherapy Response in NSCLC.
Clin Lung Cancer. 2025;26:72-77. PubMedAbstract available
LEI B, Zhang H, Sun J, Wang L, et al The Potential of Basal F-18-FDG PET/CT in Evaluating Prognosis and Benefit From
Adjuvant Chemotherapy After Tumor Resection of Stage IB(T2, = 3 cm With VPI, N0,
M0)NSCLC.
Clin Lung Cancer. 2025;26:18-28. PubMedAbstract available
SATO J, Yanagawa M, Nishigaki D, Hata A, et al Radiologists Versus AI-Based Software: Predicting Lymph Node Metastasis and
Prognosis in Lung Adenocarcinoma From CT Under Various Image Display Conditions.
Clin Lung Cancer. 2025;26:58-71. PubMedAbstract available
ZHANG J, Wang Z, Wang Y, Yu X, et al Comparison of Long-Term Survival Between Robotic and Video-Assisted Lobectomy for
Stage ? NSCLC With Radiologic Solid Tumors: A Propensity Score Matching Study.
Clin Lung Cancer. 2025;26:e63-e72. PubMedAbstract available
TAYLOR M, Martin GP, Abah U, Shackcloth M, et al Multicentre Validation of the RESECT-90 Prediction Model for 90-Day Mortality
After Lung Resection.
Clin Lung Cancer. 2025;26:e73-e80. PubMedAbstract available
December 2024
SAKANE T, Nakajima K, Iwata H, Hioki K, et al Comparison of Sublobar Resection and Proton Therapy for Early-Stage Non-small
Cell Lung Cancer.
Clin Lung Cancer. 2024 Dec 27:S1525-7304(24)00286. PubMedAbstract available
LIU M, Guan W, Xie X, Li Z, et al Phase I Clinical Trial of Autologous Hematopoietic Stem Cell
Transplantation-Supported Dose-Intensified Chemotherapy With Adebrelimab as
First-Line Treatment for Extensive-Stage Small Cell Lung Cancer.
Clin Lung Cancer. 2024 Dec 27:S1525-7304(24)00287. PubMedAbstract available
MARRONE MT, Reuss JE, Crawford A, Neelon B, et al Statin Use With Immune Checkpoint Inhibitors and Survival in Nonsmall Cell Lung
Cancer.
Clin Lung Cancer. 2024 Dec 25:S1525-7304(24)00271. PubMedAbstract available
WEI CX, Althouse SK, Mamdani H, Hanna NH, et al Association of Immune-Related Adverse Events With Efficacy in Consolidation
Nivolumab Plus Ipilimumab or Nivolumab Alone After Chemoradiation in Patients
With Unresectable Stage III Nonsmall Cell Lung Cancer: An Exploratory Analysis
From the Big 10 Ca
Clin Lung Cancer. 2024 Dec 21:S1525-7304(24)00270. PubMedAbstract available
KAWAHARA M, Matsuura Y, Nakamura S, Kinoshita F, et al Adjuvant Chemotherapy Decisions in the Treatment of Lung Cancer Considering
Nonrelapse Mortality: A Multicenter Study.
Clin Lung Cancer. 2024 Dec 21:S1525-7304(24)00272. PubMedAbstract available
GOLDMAN JW, Bueno AM, Dooms C, Jhaveri K, et al Neratinib Efficacy in Patients With EGFR Exon 18-Mutant Non-Small-Cell Lung
Cancer: Findings From the SUMMIT Basket Trial.
Clin Lung Cancer. 2024 Dec 11:S1525-7304(24)00266. PubMedAbstract available
TAKEDA M, Ota M, Iwama E, Sugawara S, et al A Phase II, Open Label, Single-Arm Study on the Efficacy of Cabozantinib in
Patients With Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring MET Exon 14
Alterations who Developed Acquired Resistance to Tepotinib or Capmatinib (CAPTURE
Trial).
Clin Lung Cancer. 2024 Dec 9:S1525-7304(24)00267. PubMedAbstract available
ENRICO D, Gomez JE, Aguirre D, Tissera NS, et al Efficacy of First-Line Nivolumab Plus Ipilimumab in Unresectable Pleural
Mesothelioma: A Multicenter Real-World Study (ImmunoMeso LATAM).
Clin Lung Cancer. 2024;25:723-731. PubMedAbstract available
HUET C, Basse C, Knetki-Wroblewska M, Chilczuk P, et al Outcomes Analysis of Patients Receiving Local Ablative Therapy for
Oligoprogressive Metastatic NSCLC Under First-Line Immunotherapy.
Clin Lung Cancer. 2024;25:e402-e410. PubMedAbstract available
LEONETTI A, Cervati V, Minari R, Scarlattei M, et al Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of
Osimertinib Treatment in Advanced EGFR-Mutated NSCLC.
Clin Lung Cancer. 2024;25:e436-e445. PubMedAbstract available
DAMHUIS R, Bahce I, Senan S Association Between PD-L1 Score and the Outcomes of Consolidation Durvalumab in a
Large Nationwide Series of Patients With Stage III NSCLC Treated With
Chemoradiotherapy.
Clin Lung Cancer. 2024;25:683-689. PubMedAbstract available
SMITH MR, Wang Y, Dixon CB, D'Agostino R, et al Mutations Associated With High-Grade irAEs in NSCLC Patients Receiving
Immunotherapies.
Clin Lung Cancer. 2024;25:e379-e388. PubMedAbstract available
LARA MS, Riess JW, Goldman JW, Jiang F, et al Current Trial Report: A Multicenter Phase I/Ib study of Capmatinib Plus
Trametinib in Patients With Metastatic Nonsmall Cell Lung Center Harboring MET
Exon 14 Skipping Mutations and Other MET-Alterations.
Clin Lung Cancer. 2024;25:732-737. PubMedAbstract available
November 2024
WANG M, Wang X, Yang R, Geng M, et al Conversion Surgery for Initially Unresectable Stage ? Nonsmall Cell Lung Cancer
After Induction Treatment of Immunochemotherapy: A Multicenter Study.
Clin Lung Cancer. 2024 Nov 28:S1525-7304(24)00249. PubMedAbstract available
GHARZAI LA, Bell S, Gupta DM, Carlos RC, et al Impact of Lung Biomarker Testing on Out-Of-Pocket Costs for Metastatic
Non-Small-Cell Lung Cancer.
Clin Lung Cancer. 2024 Nov 23:S1525-7304(24)00255. PubMedAbstract available
WHITEHORN GL, Rshaidat H, Madeka I, Martin J, et al Lobectomy Is Not Associated With Improved Survival as Compared to Segmentectomy
in Early-Stage Lung Cancer Patients With Visceral Pleural Invasion.
Clin Lung Cancer. 2024 Nov 18:S1525-7304(24)00253. PubMedAbstract available
STUMM TW, Mina S, Okusanya O, Cowan S, et al Metrics for Perioperative Exercise in Patients Undergoing Lung Cancer Resection:
A Systematic Review.
Clin Lung Cancer. 2024 Nov 16:S1525-7304(24)00252. PubMedAbstract available
LIU J, Cao B, Shi Z, Song M, et al Correlation Between the Extent of N1 Lymph Node Station Examination and Prognosis
in Stage I Non-small Cell Lung Cancer Patients: One Station is Insufficient.
Clin Lung Cancer. 2024 Nov 16:S1525-7304(24)00250. PubMedAbstract available
PARK JA, Pham D, Nilsson K, Ramsey L, et al Enhanced Recovery With Aggressive Ambulation Decreases Length of Stay in Lung
Cancer Surgery.
Clin Lung Cancer. 2024 Nov 16:S1525-7304(24)00251. PubMedAbstract available
LIBBY DM, Libby LJ, Ma X, Chua J, et al Association of Oncogene Driver Mutations with Recurrence and Survival in Stage I
Nonsmall Cell Lung Cancer.
Clin Lung Cancer. 2024 Nov 14:S1525-7304(24)00233. PubMedAbstract available
GARCIA C, Abrahami D, Polli A, Chu H, et al Comparative Efficacy and Safety of Lorlatinib Versus Alectinib and Lorlatinib
Versus Brigatinib for ALK-Positive Advanced/Metastatic NSCLC: Matching-Adjusted
Indirect Comparisons.
Clin Lung Cancer. 2024;25:634-642. PubMedAbstract available
MURATA S, Horinouchi H, Morishita M, Kaku S, et al Impact of Durvalumab on the Duration and Complexity of Corticosteroid Therapy for
Pneumonitis After Chemoradiotherapy.
Clin Lung Cancer. 2024;25:e369-e378. PubMedAbstract available
CHOU KN, Park DJ, Hori YS, Persad AR, et al Primary Stereotactic Body Radiotherapy for Spinal Bone Metastases From Lung
Adenocarcinoma.
Clin Lung Cancer. 2024;25:e337-e347. PubMedAbstract available
DEMIR T, Araz M, Moloney C, Hendem E, et al Efficacy of Systemic Treatments in Patients With Metastatic Lung Invasive
Mucinous Adenocarcinoma.
Clin Lung Cancer. 2024;25:e316-e322. PubMedAbstract available
SCHMID S, Zhan L, Garcia M, Dietrich K, et al Immediate Versus Deferred Systemic Therapy in Patients With Mesothelioma.
Clin Lung Cancer. 2024;25:e277-e285. PubMedAbstract available
October 2024
KUMAR MS, Deshmukh S, Bhanushali C, Boumber Y, et al Biomarker Landscape of Antibody Drug Conjugates (ADCs) and Bispecific Antibodies
in Clinical Trials for Lung Cancer.
Clin Lung Cancer. 2024 Oct 31:S1525-7304(24)00222. PubMed
FORTMAN D, Wang H, VanderWeele R, Evans T, et al Brief Report: Phase II Clinical Trial of Atezolizumab in Advanced Nonsmall Cell
Lung Cancer Patients Previously Treated With PD-1-Directed Therapy.
Clin Lung Cancer. 2024 Oct 30:S1525-7304(24)00231. PubMed
MATHIOT L, Raimbourg J Comment on ;;Prognostic Impact of TP53 Mutations in Metastatic Nonsquamous
Non-small-cell Lung Cancer''.
Clin Lung Cancer. 2024 Oct 28:S1525-7304(24)00224. PubMed
JIANG L, Jiang S, Miao W, Shen Y, et al Clinical Characteristics and Management of Checkpoint Inhibitor Pneumonitis in
Non-Small-Cell Lung Cancer Patients After Neoadjuvant Immunotherapy.
Clin Lung Cancer. 2024 Oct 28:S1525-7304(24)00229. PubMedAbstract available
CHAN SWS, Zeng J, Young J, Barghout SH, et al A Poor Prognostic ALK Phenotype: A Review of Molecular Markers of Poor Prognosis
in ALK Rearranged Nonsmall Cell Lung Cancer.
Clin Lung Cancer. 2024 Oct 28:S1525-7304(24)00223. PubMedAbstract available
QASIM R, Riaz Z Comment on "Prognostic Impact of TP53 Mutations in Metastatic Nonsquamous
Non-Small-Cell Lung Cancer".
Clin Lung Cancer. 2024 Oct 25:S1525-7304(24)00225. PubMed
CHOW JCH, Chik JYK, Cheung KM, Lee LTY, et al Phrenic Nerve Palsy after Stereotactic Body Radiotherapy for Central Lung Cancer:
A Case Report.
Clin Lung Cancer. 2024 Oct 18:S1525-7304(24)00210. PubMed
LEI F, Sekkath-Veedu J, Huang B, Chen Q, et al Inclusion of Surgery in Multimodality Treatment is Predictive of Better Survival
in Stage IIIA Non-small Cell Lung Cancer: An Inverse Probability
Treatment-Weighting Analysis.
Clin Lung Cancer. 2024 Oct 18:S1525-7304(24)00221. PubMedAbstract available
SEITLINGER J, Patel D, Meng A, Bulgarelli-Maqueda L, et al Perioperative Outcomes of Neoadjuvant Therapy in Resectable Lung Cancer Patients
With Endobronchial Disease in the Era of Personalized Medicine.
Clin Lung Cancer. 2024 Oct 16:S1525-7304(24)00208. PubMedAbstract available
WONG LY, Kapula N, Kang A, Phadke AJ, et al The Role of Primary Care Providers in Lung Cancer Screening: A Cross-Sectional
Survey.
Clin Lung Cancer. 2024 Oct 9:S1525-7304(24)00206. PubMedAbstract available
JO Y, Puri S, Haaland B, Coletta AM, et al Augmenting Prognostication: Utilizing Activity Trackers to Enhance Survival
Prediction in Metastatic Non-Small Cell Lung Cancer.
Clin Lung Cancer. 2024 Oct 9:S1525-7304(24)00205. PubMedAbstract available
WHEELER M, Karanth S, Divaker J, Yoon HS, et al Participation in Non-small Cell Lung Cancer Clinical Trials in the United States
by Race/Ethnicity.
Clin Lung Cancer. 2024 Oct 4:S1525-7304(24)00204. PubMedAbstract available
YOSHIOKA H, Ishida T, Atagi S, Tamiya A, et al Randomized Phase II Trial of Amrubicin Plus Irinotecan Versus Cisplatin Plus
Irinotecan in Chemo-naive Patients With Extensive-Disease Small-Cell Lung Cancer:
Results of the Japan Multinational Trial Organization (JMTO) LC 08-01.
Clin Lung Cancer. 2024 Oct 1:S1525-7304(24)00197. PubMedAbstract available
PRICE SN, Willis AR, Hensley A, Hyson J, et al Implementation and Retrospective Examination of a Lung Cancer Survivorship Clinic
in a Comprehensive Cancer Center.
Clin Lung Cancer. 2024 Oct 1:S1525-7304(24)00203. PubMedAbstract available
September 2024
RSHAIDAT H, Mack SJ, Koeneman SH, Martin J, et al The Role of Medicaid Expansion on the Receipt of Adjuvant Chemotherapy in
Patients With Lung Cancer.
Clin Lung Cancer. 2024 Sep 24:S1525-7304(24)00202. PubMedAbstract available
ROBINSON ND, Canavan ME, Zhan PL, Udelsman BV, et al Treatment Patterns and Clinical Outcomes in Patients With EGFR-Mutated
Non-Small-Cell Lung Cancer After Progression on Osimertinib.
Clin Lung Cancer. 2024 Sep 23:S1525-7304(24)00201. PubMedAbstract available
SPICER J, Blais N, Owen S, Robinson AG, et al A Phase II Study of Neoadjuvant Opnurasib KRAS G12C Inhibitor in Patients With
Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of
the IND.242 Platform Master Protocol.
Clin Lung Cancer. 2024 Sep 20:S1525-7304(24)00198. PubMedAbstract available
WATSON AS, Krause HB, Elliott A, Farrell A, et al Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the
Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain
in Nonsmall Cell Lung Cancer.
Clin Lung Cancer. 2024 Sep 12:S1525-7304(24)00196. PubMedAbstract available
GRABER-NAIDICH A, Choi E, Wu JT, Ellis-Caleo TJ, et al Smoking and the Risk of Second Primary Lung Cancer Among Breast Cancer Survivors
from the Population-Based UK Biobank Study.
Clin Lung Cancer. 2024 Sep 6:S1525-7304(24)00195. PubMedAbstract available
MEYER ML, Gros L, Decosterd N, Tagliamento M, et al Brief Report: Targeted Therapies and Pancreatitis in Patients With Advanced
Nonsmall Cell Lung Cancer.
Clin Lung Cancer. 2024 Sep 3:S1525-7304(24)00194. PubMed
RECK M, Nadal E, Girard N, Filippi AR, et al MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery
and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in
Resectable or Borderline-resectable Stage IIB-IIIB NSCLC.
Clin Lung Cancer. 2024;25:587-593. PubMedAbstract available
HISHIDA T, Okami J, Asamura H, Miyaoka E, et al Clinicopathological Features and Survival Outcomes of Resected Lung Adenosquamous
Carcinoma: Results From a Nationwide Japanese Registry Data.
Clin Lung Cancer. 2024;25:519-528. PubMedAbstract available
VELCHETI V, Rai P, Kao YH, Chirovsky D, et al 5-Year Real-World Outcomes With Frontline Pembrolizumab Monotherapy in PD-L1
Expression >/= 50% Advanced NSCLC.
Clin Lung Cancer. 2024;25:502-508. PubMedAbstract available
RSHAIDAT H, Whitehorn GL, Collins M, Mack SJ, et al Factors Associated With Margin Positivity After Lung Resection Surgery.
Clin Lung Cancer. 2024;25:560-566. PubMedAbstract available
CONCANNON KF, Glisson BS, Doebele RC, Huang C, et al A Phase I Open-Label Study of Cediranib Plus Etoposide and Cisplatin as
First-Line Therapy for Patients With Extensive-Stage Small-Cell Lung Cancer or
Metastatic Neuroendocrine Non-Small-Cell Lung Cancer.
Clin Lung Cancer. 2024 Sep 1:S1525-7304(24)00193. PubMedAbstract available
August 2024
NARRA K, Ghabach B, Athipatla V, Blackwell JM, et al Identification and Treatment of Lung Cancer Oncogenic Drivers in a Diverse Safety
Net Setting.
Clin Lung Cancer. 2024 Aug 31:S1525-7304(24)00192. PubMedAbstract available
KAPP CM, Green C, Thiboutot J, Kim J, et al Understanding the Social Risk Factors That Avert Equitable Lung Cancer Care.
Clin Lung Cancer. 2024 Aug 31:S1525-7304(24)00190. PubMedAbstract available
WU J, Thomas T, Tavalire HF, Vecchio F, et al Letter to the Editor in Response to "Adherence to Annual Lung Cancer Screening in
a Centralized Academic Program".
Clin Lung Cancer. 2024 Aug 30:S1525-7304(24)00181. PubMed
TISSERA S, Billah B, Brand M, Karim MN, et al Stage-Specific Guideline Concordant Treatment Impacts on Survival in Nonsmall
Cell Lung Cancer: A Novel Quality Indicator.
Clin Lung Cancer. 2024 Aug 24:S1525-7304(24)00191. PubMedAbstract available
OHRI N, Bodner W, Garg M, Stiles B, et al Untapping the Prognostic Value of Patient-Generated Health Data in Locally
Advanced Non-small Cell Lung Cancer.
Clin Lung Cancer. 2024 Aug 23:S1525-7304(24)00182. PubMedAbstract available
ZENG H, Hendriks LEL, Belderbos J, Brandts L, et al Association of Serum Biomarkers With Neurocognitive Decline After PCI in Small
Cell Lung Cancer: An Exploratory Study of the Phase III NCT01780675 Trial.
Clin Lung Cancer. 2024 Aug 22:S1525-7304(24)00180. PubMedAbstract available
PARK JA, Yalamanchili S, Brown Z, Myers A, et al Implementation of an Electronic Medical Record Alert Significantly Increases Lung
Cancer Screening Uptake.
Clin Lung Cancer. 2024 Aug 18:S1525-7304(24)00157. PubMedAbstract available
PAN H, Luo Q "Video Assisted Thoracoscopic Surgery Versus Thoracotomy Following Neoadjuvant
Immunochemotherapy in Resectable Stage III Non-Small Cell Lung Cancer Among
Chinese Population: A Multicenter Retrospective Cohort Study".
Clin Lung Cancer. 2024 Aug 17:S1525-7304(24)00179. PubMed
QASIM R, Riaz Z Video Assisted Thoracoscopic Surgery Versus Thoracotomy Following Neoadjuvant
Immunochemotherapy in Resectable Stage III Non-Small Cell Lung Cancer Among
Chinese Population: A Multicenter Retrospective Cohort Study.
Clin Lung Cancer. 2024 Aug 16:S1525-7304(24)00178. PubMed
LIU J, Yang Y, Wu D, Li H, et al Efficacy of Prophylactic Cranial Irradiation in Early to Mid-stage Small Cell
Lung Cancer Patients in the Era of Magnetic Resonance Imaging.
Clin Lung Cancer. 2024 Aug 13:S1525-7304(24)00160. PubMedAbstract available
BESTVINA CM, Hara JHL, Karrison T, Bowar B, et al DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage
Small Cell Lung Cancer.
Clin Lung Cancer. 2024 Aug 13:S1525-7304(24)00159. PubMedAbstract available
SOTO-LANZA F, Glick L, Chan C, Zhong L, et al Long-Term Clinical, Radiological, and Mortality Outcomes Following Pneumonitis in
Nonsmall Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A
Retrospective Analysis.
Clin Lung Cancer. 2024 Aug 3:S1525-7304(24)00155. PubMedAbstract available
JIANG H, Sun N, Li R, Guan W, et al Evaluating Safety and Clinical Activity of Front-line Treatment with Cadonilimab
plus Chemotherapy in Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring
STK11 Genetic Aberration: A Protocol of Phase II Study.
Clin Lung Cancer. 2024 Aug 1:S1525-7304(24)00143. PubMedAbstract available
July 2024
MA J, Peng M, Bi J, Chen Q, et al Single-drug Chemotherapy Plus Immunotherapy as First-line Treatment for Stage ?
Non-small Cell Lung Cancer Elderly Patients: A Phase II Clinical Trial UNICORN
Study.
Clin Lung Cancer. 2024 Jul 27:S1525-7304(24)00144. PubMedAbstract available
KAWACHI H, Tamiya M, Oya Y, Saito G, et al Real-World Outcomes of Subsequent Chemotherapy after Progression Following
Chemoradiation and Consolidative Durvalumab Therapy in Locally Advanced Non-small
Cell Lung Cancer: An Exploratory Analysis from the CRIMSON Study (HOPE-005).
Clin Lung Cancer. 2024 Jul 25:S1525-7304(24)00152. PubMedAbstract available
REYES A, Afkhami M, Massarelli E, Fricke J, et al RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy
in Non-Small-Cell Lung Cancer.
Clin Lung Cancer. 2024 Jul 23:S1525-7304(24)00148. PubMedAbstract available
AVANCINI A, Giannarielli D, Belluomini L, Schena F, et al Physical Exercise During Neoadjuvant Treatments for Non-Small Cell Lung Cancer:
The Time is Coming.
Clin Lung Cancer. 2024 Jul 23:S1525-7304(24)00153. PubMed
ACKER F, Klein A, Rasokat A, Eisert A, et al Multicenter Real-World Analysis of Combined MET and EGFR Inhibition in Patients
With Non-Small Cell Lung Cancer and Acquired MET Amplification or Polysomy After
EGFR Inhibition.
Clin Lung Cancer. 2024 Jul 23:S1525-7304(24)00151. PubMedAbstract available
JHA P, Joshi A, Mishra R, Biswal RP, et al Landscape of Clinically Relevant Genomic Alterations in the Indian Non-small Cell
Lung Cancer Patients.
Clin Lung Cancer. 2024 Jul 22:S1525-7304(24)00149. PubMedAbstract available
SOMISETTY M, Mack PC, Hsu CY, Huang Y, et al Characteristics of Lung Cancer Patients With Asymptomatic or Undiagnosed
SARS-CoV-2 Infections.
Clin Lung Cancer. 2024 Jul 20:S1525-7304(24)00145. PubMedAbstract available
BENNATI C, Ferrara R, Sangaletti S, Tamberi S, et al The EXcellenT Trial: Exercise in Extended Oncogene Addicted Lung Cancer in Active
Treatment.
Clin Lung Cancer. 2024 Jul 15:S1525-7304(24)00146. PubMedAbstract available
ZHAO JY, Presley C, Madariaga ML, Ferguson M, et al Prehabilitation for Older Adults Undergoing Lung Cancer Surgery: A Literature
Review and Needs Assessment.
Clin Lung Cancer. 2024 Jul 10:S1525-7304(24)00142. PubMedAbstract available
KAKIUCHI Y, Saruwatari K, Murotani K, Tokito T, et al Real-World Efficacy and Safety of Durvalumab Administration Following
Chemoradiotherapy in Elderly Patients With Unresectable Locally Advanced Nonsmall
Cell Lung Cancer: A Multicenter, Retrospective Study.
Clin Lung Cancer. 2024 Jul 6:S1525-7304(24)00139. PubMedAbstract available
GANDARA DR, Subramanian J, Santos ES, Brody Y, et al Impact of PROphet Test in Changing Physicians' Therapeutic Decision-Making for
Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer.
Clin Lung Cancer. 2024 Jul 2:S1525-7304(24)00138. PubMedAbstract available
SHIBAHARA D, Tanaka K, Togao O, Shiraishi Y, et al Bevacizumab for Brain Radiation Necrosis in Patients With Nonsquamous Nonsmall
Cell Lung Cancer.
Clin Lung Cancer. 2024 Jul 2:S1525-7304(24)00135. PubMed
SHARMA P, Mahadevia H, Donepudi S, Kujtan L, et al A Novel EGFR Germline Mutation in Lung Adenocarcinoma: Case Report and Literature
Review.
Clin Lung Cancer. 2024;25:479-482. PubMed
KUDO Y, Nakamura T, Matsubayashi J, Ichinose A, et al AI-driven Characterization of Solid Pulmonary Nodules on CT Imaging for Enhanced
Malignancy Prediction in Small-sized Lung Adenocarcinoma.
Clin Lung Cancer. 2024;25:431-439. PubMedAbstract available
PETRINI I, Bruno R, Di Stefano I, Aprile V, et al A patient with a Germline (p.R776H) EGFR Mutation With Multiple Lung Cancers
Harboring Different Somatic EGFR Mutations.
Clin Lung Cancer. 2024;25:e238-e242. PubMed
June 2024
RECK M, De T, Paz-Ares L, Edmondson-Jones M, et al Treatment-Switching Adjustment of Overall Survival in CheckMate 227 Part 1
Evaluating First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy for
Metastatic Nonsmall Cell Lung Cancer.
Clin Lung Cancer. 2024 Jun 29:S1525-7304(24)00131. PubMedAbstract available
KELTNER S, Esslinger H, Wu X, Rai S, et al Refining Surveillance Guidelines after Stereotactic Body Radiation Therapy for
Early-Stage Lung Cancer.
Clin Lung Cancer. 2024 Jun 21:S1525-7304(24)00134. PubMedAbstract available
SHAH AT, Blanchard I, Padda SK, Wakelee HA, et al Molecular Characteristics and Pretreatment Neutrophil-to-Lymphocyte Ratio as
Predictors of Durable Clinical Benefit from Immune Checkpoint Inhibition in
Non-Small Cell Lung Cancer.
Clin Lung Cancer. 2024 Jun 19:S1525-7304(24)00133. PubMedAbstract available
ZHANG Y, Chen Z, Chen G, Huang Y, et al The Design for a Phase II, Randomized, Multicenter Study of CtDNA-Guided
Treatment With Furmonertinib Combined Therapy or Furmonertinib Alone for
Untreated Advanced EGFR Mutant Non-small-cell Lung Cancer Patients: The FOCUS-C
Study.
Clin Lung Cancer. 2024 Jun 10:S1525-7304(24)00111. PubMedAbstract available
MUSCOLINO P, Scimone C, Sapuppo E, Micali V, et al Gefitinib Resensitization After a TKI-Free Interval in Osimertinib Resistant
Non-Small-Cell Lung Cancer: A Glimpse of Hope in Time of Crisis?
Clin Lung Cancer. 2024 Jun 10:S1525-7304(24)00112. PubMed
WU X, Stabile LP, Burns TF The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer
Brain Metastases.
Clin Lung Cancer. 2024 Jun 10:S1525-7304(24)00124. PubMedAbstract available
ROBINSON LA, Tanvetyanon T, Robinson NA, Bryant S, et al Surgery and Stereotactic Radiotherapy for Stage I Small-Cell Lung Carcinoma: A
25-Year Experience.
Clin Lung Cancer. 2024 Jun 8:S1525-7304(24)00110. PubMedAbstract available
GALLINA FT, Chiappetta M, Taje R, Forcella D, et al Neutrophil-to-Lymphocyte Ratio and Risk of Nodal Metastasis in Early-Stage Lung
Adenocarcinoma: A Brief Report From a Multicentric Analysis.
Clin Lung Cancer. 2024;25:e196-e200. PubMed
PARK JE, Hong KS, Choi SH, Lee SY, et al Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With
Unresectable Stage III NSCLC: A Real-World Multicenter Study.
Clin Lung Cancer. 2024;25:354-364. PubMedAbstract available
WU E, Reznicek J, Yeldandi AV, Patel JD, et al Neoadjuvant Therapy Before Resection of Primary Pulmonary Lymphoepithelial
Carcinoma.
Clin Lung Cancer. 2024;25:376-379. PubMed
FENG A, Huang Y, Zeng Y, Shao Y, et al Improvement of Prediction Performance for Radiation Pneumonitis by Using
3-Dimensional Dosiomic Features.
Clin Lung Cancer. 2024;25:e173-e180. PubMedAbstract available
May 2024
AWIDI M, Mier-Hicks A, Perimbeti S, Attwood K, et al Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer
After Complete Surgical Resection: What Makes It Worth It to Patients?
Clin Lung Cancer. 2024 May 29:S1525-7304(24)00082. PubMedAbstract available
CHRISTENSEN NL, Gouliaev A, McPhail S, Lyratzopoulos G, et al Routes to Diagnosis in Danish Lung Cancer Patients: Emergency Presentation, Age
and Smoking History-A Population-Based Cohort Study.
Clin Lung Cancer. 2024 May 25:S1525-7304(24)00108. PubMedAbstract available
KLEEMISS M, Muller CE, Schneider M, Strotmann R, et al Tepotinib in a Patient With Advanced Non-Small Cell Lung Cancer Harboring MET
Exon 14 Skipping Undergoing Concomitant Hemodialysis for Renal Failure: A Case
Report.
Clin Lung Cancer. 2024 May 25:S1525-7304(24)00109. PubMed
THOSANI DS, Meredith LT, West R, Till BM, et al Association Between Utilization of Services and Perioperative Outcomes for Lung
Cancer Resection.
Clin Lung Cancer. 2024 May 20:S1525-7304(24)00097. PubMedAbstract available
ROUSSEAU G, Dantoing E, Leturgie B, Tillon-Strozyk J, et al Brief Report: Carboplatin, Weekly Paclitaxel and Pembrolizumab in Elderly
Patients for Advanced Non-Small Cell Lung Cancer With PD-L1 < 50%: Real-World
Data.
Clin Lung Cancer. 2024 May 18:S1525-7304(24)00084. PubMed
IWAI C, Jo T, Konishi T, Fujita A, et al Interstitial Pneumonitis Following Sequential Administration of Programmed
Death-1/Programmed Death-Ligand1 Inhibitors and Epidermal Growth Factor
Receptor-Tyrosine Kinase Inhibitors For Non-Small Cell Lung Cancer: A
Matched-Pair Cohort Study Using a
Clin Lung Cancer. 2024 May 11:S1525-7304(24)00067. PubMedAbstract available
MINNE RL, Luo NY, Traynor AM, Huang M, et al Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified
Non-small Cell Lung Cancer.
Clin Lung Cancer. 2024 May 10:S1525-7304(24)00080. PubMedAbstract available
TAYLOR M, Evison M, Michael S, Obale E, et al Pre-Operative Measures of Systemic Inflammation Predict Survival After Surgery
for Primary Lung Cancer.
Clin Lung Cancer. 2024 May 8:S1525-7304(24)00077. PubMedAbstract available
ZHANG W, Tian S, Li X, Chen Y, et al ETV6-NTRK2 Fusion in a Patient With Metastatic Pulmonary Atypical Carcinoid
Successfully Treated With Entrectinib: A Case Report and Review of the
Literature.
Clin Lung Cancer. 2024;25:215-224. PubMedAbstract available
TILL BM, Grenda T, Tidwell T, Wickes B, et al Brief Report: Nonmalignant Surgical Resection Among Individuals with
Screening-Detected Versus Incidental Lung Nodules.
Clin Lung Cancer. 2024;25:e129-e132. PubMed
April 2024
SRIDHAR A, West HJ, Singhi EK Brief Report on Global Clinician Practices in the First-Line Management of
Metastatic Non-Small Cell Lung Cancer.
Clin Lung Cancer. 2024 Apr 30:S1525-7304(24)00068. PubMedAbstract available
TANVETYANON T, Chen DT, Gray JE Timeliness of EGFR/ALK Inhibitor Treatment and Survival in Lung Cancer: A
Population-Based Analysis.
Clin Lung Cancer. 2024 Apr 30:S1525-7304(24)00078. PubMedAbstract available
LU S, Zhou Q, Liu X, Du Y, et al Updated Efficacy and Safety of Lorlatinib in a Phase 2 Study in Chinese Patients
With Previously Treated Advanced ALK-Positive Non-small Cell Lung Cancer.
Clin Lung Cancer. 2024 Apr 30:S1525-7304(24)00079. PubMedAbstract available
WONG LY, Choudhary S, Kapula N, Lin M, et al Barriers to Completing Low Dose Computed Tomography Scan for Lung Cancer
Screening.
Clin Lung Cancer. 2024 Apr 27:S1525-7304(24)00070. PubMedAbstract available
NONAKA Y, Isaka M, Matsushima K, Katsumata S, et al Prediction of Pleural Lavage Cytology According to Thin-Section Computed
Tomography in Non-Small-Cell Lung Cancer.
Clin Lung Cancer. 2024 Apr 16:S1525-7304(24)00053. PubMedAbstract available
FANTONI A, Warburton L, Solomon B, Alexander M, et al Completion of Pembrolizumab in Advanced Non-Small Cell Lung Cancer-Real World
Outcomes After Two Years of Therapy (COPILOT).
Clin Lung Cancer. 2024 Apr 15:S1525-7304(24)00051. PubMedAbstract available
JIANG Z, Li Q, Ruan J, Li Y, et al Machine Learning-Based Prediction of Pathological Responses and Prognosis After
Neoadjuvant Chemotherapy for Non-Small-Cell Lung Cancer: A Retrospective Study.
Clin Lung Cancer. 2024 Apr 12:S1525-7304(24)00049. PubMedAbstract available
ORDING AG, Christensen TD, Skjoth F, Noble S, et al Risk of Venous Thromboembolism in Patients With Stage III and IV Non-Small-Cell
Lung Cancer: Nationwide Descriptive Cohort Study.
Clin Lung Cancer. 2024 Apr 11:S1525-7304(24)00047. PubMedAbstract available
NILSSEN Y, Brustugun OT, Fjellbirkeland L, Gronberg BH, et al Small Cell Lung Cancer in Norway: Patterns of Care by Health Region and Survival
Trends.
Clin Lung Cancer. 2024 Apr 10:S1525-7304(24)00046. PubMedAbstract available
MILLS MN, Uno A, Li P, Liveringhouse C, et al Clinical Outcomes of Patients with Non-Small Cell Lung Cancer Leptomeningeal
Disease Following Receipt of EGFR-Targeted Therapy, Immune-Checkpoint Blockade,
Intrathecal Chemotherapy, or Radiation Therapy Alone.
Clin Lung Cancer. 2024 Apr 10:S1525-7304(24)00048. PubMedAbstract available
ROBERTS HN, Solomon B, Harden S, Lingaratnam S, et al Utility of 30-Day Mortality Following Systemic Anti-Cancer Treatment as a Quality
Indicator in Advanced Lung Cancer.
Clin Lung Cancer. 2024 Apr 6:S1525-7304(24)00045. PubMedAbstract available
PAN H, Chen H, Kong W, Ning J, et al Video-Assisted Thoracoscopic Surgery Versus Thoracotomy Following Neoadjuvant
Immunochemotherapy in Resectable Stage III Non-Small Cell Lung Cancer Among
Chinese Populations: A Multi-Center Retrospective Cohort Study.
Clin Lung Cancer. 2024 Apr 2:S1525-7304(24)00042. PubMedAbstract available
March 2024
DONINGTON J, Hu X, Zhang S, Song Y, et al Real-World Neoadjuvant Treatment Patterns and Outcomes in Resected Non-Small-Cell
Lung Cancer.
Clin Lung Cancer. 2024 Mar 22:S1525-7304(24)00041. PubMedAbstract available
DJUNADI TA, Oh Y, Lee J, Yu J, et al Redefining Clinical Hyperprogression: The Incidence, Clinical Implications, and
Risk Factors of Hyperprogression in Non-Small Cell Lung Cancer Treated with
Immunotherapy.
Clin Lung Cancer. 2024 Mar 16:S1525-7304(24)00036. PubMedAbstract available
GARON EB, Cho BC, Luft A, Alatorre-Alexander J, et al A Brief Report of Durvalumab With or Without Tremelimumab in Combination With
Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer:
Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study.
Clin Lung Cancer. 2024 Mar 15:S1525-7304(24)00038. PubMed
MARMARELIS ME, Scholes DG, McGrath CM, Priore SF, et al Brief Report: Impact of Reflex Testing on Tissue-Based Molecular Genotyping in
Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.
Clin Lung Cancer. 2024 Mar 12:S1525-7304(24)00037. PubMed
NOURMOHAMMADI N, Liang THP, Sadigh G Patient-Provider Lung Cancer Screening Discussions: An Analysis of a National
Survey.
Clin Lung Cancer. 2024 Mar 2:S1525-7304(24)00034. PubMedAbstract available
MOGHANAKI D, Taylor J, Bryant AK, Vitzthum LK, et al Lung Cancer Survival Trends in the Veterans Health Administration.
Clin Lung Cancer. 2024 Mar 2:S1525-7304(24)00035. PubMedAbstract available
ARDESHIR-LARIJANI F, Maniar R, Goyal S, Loehrer PJ, et al Trop-2 Expression and Its Impact on Survival in Thymic Epithelial Tumors: Brief
Report.
Clin Lung Cancer. 2024;25:180-185. PubMed
JENNINGS EM, Camidge DR, Gadgeel S, Barker S, et al Trial Design and Optimal Determination of CNS Activity of Small Molecule Targeted
Therapy in NSCLC.
Clin Lung Cancer. 2024;25:91-99. PubMedAbstract available
VERMA S, Young S, Kennedy TAC, Carvalhana I, et al Detection of Circulating Tumor DNA After Stereotactic Ablative Radiotherapy in
Patients With Unbiopsied Lung Tumors (SABR-DETECT).
Clin Lung Cancer. 2024;25:e87-e91. PubMedAbstract available
GONZALEZ-MOSQUERA LF, Rous FA, Rogers A, Smith N, et al ALK Rearrangement Positive Lung Adenocarcinoma in Pregnancy Treated With
Alectinib: A Case Report.
Clin Lung Cancer. 2024;25:e77-e80. PubMedAbstract available
BORGHETTI P, Facheris G, Ciammella P, Galaverni M, et al Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic
SCLC: The SAMOS Cohort.
Clin Lung Cancer. 2024;25:151-158. PubMedAbstract available
INNO A, Picece V, Bogina G, Settanni G, et al Niraparib for the Treatment of Metastatic NSCLC in a Patient With BRCA2 Germinal
Mutation: A Case Report.
Clin Lung Cancer. 2024;25:175-179. PubMed
February 2024
GEORGE B, Baydoun A, Bhat S, Bailey L, et al Invasive Nodal Staging via Endobronchial Ultrasound and Outcome in Patients
Treated with Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell
Lung Cancer - Results from a Single Institution Study.
Clin Lung Cancer. 2024 Feb 24:S1525-7304(24)00030. PubMedAbstract available
KHOKHAR B, Chiang B, Iglay K, Reynolds K, et al QT-Interval Prolongation, Torsades de Pointes, and Heart Failure With EGFR
Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: Systematic Review.
Clin Lung Cancer. 2024 Feb 17:S1525-7304(24)00016. PubMedAbstract available
PONVILAWAN B, Mahadevia H, Qasim H, Sharma P, et al Brief Report: Evaluating the Impact of Perioperative Immune Checkpoint Inhibitor
in the Treatment of Patients with Resectable Non-Small Cell Lung Cancer: A
Systematic Review and Meta-Analysis.
Clin Lung Cancer. 2024 Feb 15:S1525-7304(24)00014. PubMed
D'AIELLO A, Stiles B, Ohri N, Levy B, et al Perioperative Immunotherapy for Non-Small Cell Lung Cancer: Practical Application
of Emerging Data and New Challenges.
Clin Lung Cancer. 2024 Feb 13:S1525-7304(24)00015. PubMedAbstract available
WU Y, Zhao Y, Wu Y, Chen H, et al A Retrospective Real-World Study of Prognostic Factors Associated With EGFR
Mutated Lung Cancer With Leptomeningeal Metastasis.
Clin Lung Cancer. 2024 Feb 8:S1525-7304(24)00012. PubMedAbstract available
OKUMA Y, Shintani Y, Sekine I, Shukuya T, et al Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in
Metastatic Non-Small Cell Lung Cancer Patients with Poor Performance Status and
Epidermal Growth Factor Receptor Mutations: Findings from the Japanese Lung
Cancer Registry Data
Clin Lung Cancer. 2024 Feb 2:S1525-7304(24)00007. PubMedAbstract available
January 2024
FIROZ WA, Sen F, Kiuru M, Huang V, et al A Case of ROS1-Fusion Non-Small Cell Lung Cancer with Acquired BRAF Mutation
Developing Unusual Skin Metastasis.
Clin Lung Cancer. 2024 Jan 30:S1525-7304(24)00011. PubMed
MATSUBARA T, Yamaguchi M, Shimokawa M, Okamoto I, et al Phase II Trial of Adjuvant Atezolizumab Therapy in Elderly Patients with
Completely Resected Stage II/III Non-Small Cell Lung Cancer: RELIANCE Trial.
Clin Lung Cancer. 2024 Jan 28:S1525-7304(24)00010. PubMedAbstract available
KAMIGAICHI A, Hamada A, Tsuboi M, Yoshimura K, et al A Multi-Institutional, Randomized, Phase III Trial Comparing Anatomical
Segmentectomy and Lobectomy for Clinical Stage IA3 Pure-Solid Non-Small-Cell Lung
Cancer: West Japan Oncology Group Study WJOG16923L (STEP UP Trial).
Clin Lung Cancer. 2024 Jan 26:S1525-7304(24)00006. PubMedAbstract available
TSUBOKAWA N, Mimae T, Mimura T, Kamigaichi A, et al Clinical Significance of Preserving Pulmonary Function After Lung Resection in
Early-Stage Non-Small-Cell Lung Cancer.
Clin Lung Cancer. 2024 Jan 26:S1525-7304(24)00005. PubMedAbstract available
WALIANY S, Neal JW, Engel-Nitz N, Lam C, et al HER2-Mutant Advanced and/or Metastatic Non-Small-Cell Lung Cancer: A US
Electronic Health Records Database Analysis of Clinical Characteristics,
Treatment Practice Patterns, and Outcomes.
Clin Lung Cancer. 2024 Jan 18:S1525-7304(24)00004. PubMedAbstract available
RODRIGUEZ-ABREU D, Bosch-Barrera J, Gray JE, Ahn MJ, et al STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in
Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated
Metastatic Non-Small Cell Lung Cancer With No Actionable Gene Alterations.
Clin Lung Cancer. 2024 Jan 6:S1525-7304(23)00267. PubMedAbstract available
CHEN Q, Wang J, Wang X, Yin Y, et al Influence of Tumor Cavitation on Assessing the Clinical Benefit of Anti-PD1 or
PD-L1 Inhibitors in Advanced Lung Squamous Cell Carcinoma.
Clin Lung Cancer. 2024;25:29-38. PubMedAbstract available
MAO S, Rosner S, Forde PM, Chaft JE, et al A Brief Report on the Patterns of Mediastinal Nodal Failure in Resectable Stage
IB-IIIA NSCLC Treated With Neoadjuvant Immunotherapy Combinations, a Secondary
Analysis of a Prospective Trial.
Clin Lung Cancer. 2024;25:e67-e71. PubMed
HAYASAKA K, Takeda H, Sakurada A, Matsumura Y, et al Clinical, Genomic, and Transcriptomic Featurses of Lung Adenocarcinoma With
Uncommon EGFR Mutation.
Clin Lung Cancer. 2024;25:e43-e51. PubMedAbstract available
ORLANDI R, Leuzzi G, Rolli L, Ferrari M, et al Long-Term Survival Analysis of Pleural Mesothelioma Patients Undergoing Surgery:
Brief Report From a Tertiary Referral Centre.
Clin Lung Cancer. 2024;25:e5-e10. PubMedAbstract available
GAO M, Wang L, Jing F, Zhang F, et al The Efficacy of Pemigatinib in Advanced NSCLC With FGFR Aberration: Case Report.
Clin Lung Cancer. 2024;25:e62-e66. PubMed
KASHIZAKI F, Chen H, Miyasaka A, Tsuchiya N, et al Safety of Readministration of EGFR-TKI After Onset of Interstitial Lung Disease
in Advanced EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis.
Clin Lung Cancer. 2024;25:e52-e57. PubMedAbstract available
JURICA JM, Carsten B, Balakhani S, Haag MM, et al CSF Cytology Identifies Mechanisms of Tyrosine Kinase Inhibitor Resistance in
Patient With EGFR-Mutated NSCLC With CNS Progression.
Clin Lung Cancer. 2024;25:77-79. PubMed
SOO RA, de Marinis F, Han JY, Ho JC, et al TARGET: A Phase II, Open-Label, Single-Arm Study of 5-Year Adjuvant Osimertinib
in Completely Resected EGFR-Mutated Stage II to IIIB NSCLC Post Complete Surgical
Resection.
Clin Lung Cancer. 2024;25:80-84. PubMedAbstract available
LU K, Woodward BD, Boys J, Onaitis M, et al Brief Report: Evaluation of Molecular Profiling Strategies for Neoadjuvant
Osimertinib in Stage IIIA EGFR-Mutant NSCLC.
Clin Lung Cancer. 2024;25:e58-e61. PubMed
FRIEDES C, Yegya-Raman N, Zhang S, Iocolano M, et al Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and
Use of Local Therapy in Patients With Oligoprogression.
Clin Lung Cancer. 2024;25:50-60. PubMedAbstract available
December 2023
DETTERBECK F, Ely S, Udelsman B, Blasberg J, et al So Now We Know-Reflections on the Extent of Resection for Stage I Lung Cancer.
Clin Lung Cancer. 2023 Dec 28:S1525-7304(23)00262. PubMedAbstract available
JANG C, Lau SC, Velcheti V To Crush or Not to Crush: Administering Dabrafenib and Trametinib Through a
Nasogastric Tube in a Critically Ill Patient With Nonsmall Cell Lung Cancer - A
Case Report and Review of Literature of Targeted Therapies Given Through Enteral
Feeding Tubes.
Clin Lung Cancer. 2023 Dec 27:S1525-7304(23)00270. PubMedAbstract available
RAMANATHAN S, Hochstedler KA, Laucis AM, Movsas B, et al Predictors of Early Hospice or Death in Patients With Inoperable Lung Cancer
Treated With Curative Intent.
Clin Lung Cancer. 2023 Dec 27:S1525-7304(23)00283. PubMedAbstract available
BARSOUK A, Friedes C, Iocolano M, Doucette A, et al Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated
Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab
Consolidation.
Clin Lung Cancer. 2023 Dec 22:S1525-7304(23)00266. PubMedAbstract available
PRELAJ A, Ganzinelli M, Provenzano L, Mazzeo L, et al APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With
Innovative Therapies: Integration of Real-World Data and Translational Research.
Clin Lung Cancer. 2023 Dec 22:S1525-7304(23)00269. PubMedAbstract available
VERSCHUEREN MV, Peters BJ, Bloem LT, Kruik VR, et al Pembrolizumab Plus Chemotherapy Per PD-L1 Stratum In Patients With Metastatic
Non-Small Cell Lung Cancer: Real-World Effectiveness Versus Trial Efficacy.
Clin Lung Cancer. 2023 Dec 20:S1525-7304(23)00268. PubMedAbstract available
PILON Y, Rokah M, Seitlinger J, Sepesi B, et al Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer:
Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network.
Clin Lung Cancer. 2023 Dec 19:S1525-7304(23)00264. PubMedAbstract available
CAO J, Zhang C, Zhang X, Liu L, et al The Clinical Outcomes of Thoracoscopic Versus Open Lobectomy for Non-Small-Cell
Lung Cancer After Neoadjuvant Therapy: A Multi-Center Retrospective Cohort Study.
Clin Lung Cancer. 2023 Dec 16:S1525-7304(23)00263. PubMedAbstract available
SCHOENMAEKERS J, Dijkstra J, van der Wekken A, Paats M, et al In-depth Analysis of Lorlatinib-related neurocognitive Adverse Events in Patients
With Non-small-cell Lung Cancer.
Clin Lung Cancer. 2023 Dec 13:S1525-7304(23)00261. PubMedAbstract available
MATHIOT L, Nigen B, Goronflot T, Hiret S, et al Prognostic Impact of TP53 Mutations in Metastatic Nonsquamous Non-small-cell Lung
Cancer.
Clin Lung Cancer. 2023 Dec 13:S1525-7304(23)00260. PubMedAbstract available
CALI DAYLAN AE, Maia CM, Attarian S, Guo X, et al HIV Associated Lung Cancer: Unique Clinicopathologic Features and Immune
Biomarkers Impacting Lung Cancer Screening and Management.
Clin Lung Cancer. 2023 Dec 12:S1525-7304(23)00259. PubMedAbstract available
FAN Y, Drilon A, Chiu CH, Loong HHF, et al Brief Report: Updated Efficacy and Safety Data From an Integrated Analysis of
Entrectinib in Locally Advanced/Metastatic ROS1 Fusion-Positive Non-Small-Cell
Lung Cancer.
Clin Lung Cancer. 2023 Dec 7:S1525-7304(23)00258. PubMed
OU SI, Prawitz T, Lin HM, Hong JL, et al Efficacy of Mobocertinib and Amivantamab in Patients With Advanced Non-Small Cell
Lung Cancer With EGFR Exon 20 Insertions Previously Treated With Platinum-Based
Chemotherapy: An Indirect Treatment Comparison.
Clin Lung Cancer. 2023 Dec 4:S1525-7304(23)00254. PubMedAbstract available
GROSS AJ, Sheikh S, Kharouta M, Chaung K, et al The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic
Radiation Therapy for Extensive Stage Small-Cell Lung Cancer in the Transition to
the Chemo-Immunotherapy Era: A Single Institution Series.
Clin Lung Cancer. 2023;24:696-705. PubMedAbstract available
VISONA G, Spiller LM, Hahn S, Hattingen E, et al Machine-Learning-Aided Prediction of Brain Metastases Development in
Non-Small-Cell Lung Cancers.
Clin Lung Cancer. 2023;24:e311-e322. PubMedAbstract available
FARIA N, Lacerda C, Lopes J, Viana C, et al PET-CT SUV(max) and Endobronchial Ultrasound Features for Prediction of
Malignancy: A Prospective Study.
Clin Lung Cancer. 2023;24:753-760. PubMedAbstract available
LI S, Chen M, Wang Y, Li X, et al An Effective Malignancy Prediction Model for Incidentally Detected Pulmonary
Subsolid Nodules Based on Current and Prior CT Scans.
Clin Lung Cancer. 2023;24:e301-e310. PubMedAbstract available
VINDUM HH, Kristensen K, Christensen NL, Madsen HH, et al Outcome of Incidental Pulmonary Nodules in a Real-World Setting.
Clin Lung Cancer. 2023;24:673-681. PubMedAbstract available
GHANEM P, Murray JC, Hsu M, Guo MZ, et al Clinical and Genomic Characterization of Long-Term Responders Receiving Immune
Checkpoint Blockade for Metastatic Non-Small-Cell Lung Cancer.
Clin Lung Cancer. 2023 Dec 1:S1525-7304(23)00255. PubMedAbstract available
November 2023
PORTE M, Vaudron A, Crequit P, Vaugier L, et al A Multicenter Study Assessing the Real-World Use and Effectiveness of First-Line
Chemotherapy Plus Immunotherapy in Advanced Small-Cell Lung Cancer (SCLC)
Patients.
Clin Lung Cancer. 2023 Nov 23:S1525-7304(23)00252. PubMedAbstract available
LIU J, Xiang Y, Fang T, Zeng L, et al Advances in the Diagnosis and Treatment of Advanced Non-Small-Cell Lung Cancer
With EGFR Exon 20 Insertion Mutation.
Clin Lung Cancer. 2023 Nov 23:S1525-7304(23)00253. PubMedAbstract available
RIUDAVETS M, Auclin E, Mosteiro M, Dempsey N, et al Association Between Lung Immune Prognostic Index and Durvalumab Consolidation
Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer.
Clin Lung Cancer. 2023 Nov 22:S1525-7304(23)00242. PubMedAbstract available
HUI C, Marquez C, Lau B, Das M, et al Patient Selection and Outcomes for Hypofractionated Accelerated Radiation and
Concurrent Chemotherapy for Non-Small-Cell Lung Cancer.
Clin Lung Cancer. 2023 Nov 21:S1525-7304(23)00243. PubMedAbstract available
OHRI N, Chudgar NP, Vimolratana M, Cheng H, et al Comments on "Effect of Surgical Treatment for N2-Positive c-Stage III Non-Small
Cell Lung Carcinoma in the "PACIFIC" Era".
Clin Lung Cancer. 2023 Nov 14:S1525-7304(23)00227. PubMed
HUI C, Brown E, Wong S, Das M, et al Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer: Protocol for a
Bayesian Optimal Phase I/II Trial.
Clin Lung Cancer. 2023 Nov 8:S1525-7304(23)00230. PubMedAbstract available
SAWA K, Ihara Y, Imai T, Sugimoto A, et al Lack of Association Between Immunotherapy and Improvement of Survival for
Non-small Cell Lung Cancer Patients With Hemodialysis: A Nationwide Retrospective
Cohort Study.
Clin Lung Cancer. 2023 Nov 7:S1525-7304(23)00229. PubMedAbstract available
ADACHI H, Ito H, Isaka T, Saito H, et al Sufficient Multidisciplinary Discussion Can Make Patients' Outcomes Better in the
Treatment for Stage III Non-Small-Cell Lung Carcinoma - Reply to Ohri et al.
Clin Lung Cancer. 2023 Nov 3:S1525-7304(23)00228. PubMed
WOLF J, Souquet PJ, Goto K, Cortot A, et al Improved Survival Outcomes in Patients With MET-Dysregulated Advanced NSCLC
Treated With MET Inhibitors: Results of a Multinational Retrospective Chart
Review.
Clin Lung Cancer. 2023;24:641-650. PubMedAbstract available
FRICKE J, Wang J, Gallego N, Mambetsariev I, et al Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung
Adenocarcinoma: A Case Series.
Clin Lung Cancer. 2023;24:666-671. PubMed
MALLAEV M, Chirindel AF, Lardinois D, Tamm M, et al 3D-Quantitated Single Photon Emission Computed Tomography/Computed Tomography:
Impact on intended Management Compared to Lung Perfusion Scan in Marginal
Candidates for Pulmonary Resection.
Clin Lung Cancer. 2023;24:621-630. PubMedAbstract available
LEE KH, Chung JH, Cho S, Lee JS, et al Differential Prognostic Value of Vascular Invasion in Resected Lung
Adenocarcinomas According to Epidermal Growth Factor Receptor Mutational Status.
Clin Lung Cancer. 2023;24:e291-e299. PubMedAbstract available
ASAO T, Shukuya T, Mimori T, Goto Y, et al Study Design and Rationale for Marble Study: A Phase II Trial of Atezolizumab
(MPDL3280A) Plus Carboplatin and Paclitaxel in Patients With Advanced or
Recurrent Thymic Carcinoma (JTD2101).
Clin Lung Cancer. 2023;24:e247-e253. PubMedAbstract available
October 2023
PIRZADEH M, Lagina M, Wood C, Valley T, et al Barriers to Timely Lung Cancer Care in Early Stage Non-Small Cell Lung Cancer and
Impact on Patient Outcomes.
Clin Lung Cancer. 2023 Oct 31:S1525-7304(23)00226. PubMedAbstract available
QIN A, Wells L, Malhotra B, Gadgeel S, et al A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously
Treated Advanced Non-Small-Cell Lung Cancer.
Clin Lung Cancer. 2023 Oct 26:S1525-7304(23)00224. PubMedAbstract available
FLOREZ N, Kiel L, Riano I, Patel S, et al Lung Cancer in Women: The Past, Present, and Future.
Clin Lung Cancer. 2023 Oct 20:S1525-7304(23)00212. PubMedAbstract available
ADACHI H, Morohoshi T, Shintani Y, Okami J, et al Benefit of Adjuvant Chemotherapy for Patients Older Than 75 Years With Completely
Resected p-Stage II-IIIA Non-Small-Cell Lung Cancer: A Retrospective Cohort Study
Using Japanese Nationwide Real-World Data.
Clin Lung Cancer. 2023 Oct 12:S1525-7304(23)00192. PubMedAbstract available
ENJO-BARREIRO JR, Ruano-Ravina A, Perez-Rios M, Kelsey K, et al Genome Wide Association Studies in Small-Cell Lung Cancer. A Systematic Review.
Clin Lung Cancer. 2023 Oct 12:S1525-7304(23)00195. PubMedAbstract available
YU LEE-MATEUS A, Sawal N, Hartley C, Edell E, et al Efficacy of Robotic Bronchoscopy for Molecular Marker Analysis in Primary Lung
Cancer.
Clin Lung Cancer. 2023 Oct 12:S1525-7304(23)00194. PubMedAbstract available
LEE G, Hill LP, Schroeder MC, Kraus SJ, et al Adherence to Annual Lung Cancer Screening in a Centralized Academic Program.
Clin Lung Cancer. 2023 Oct 12:S1525-7304(23)00193. PubMedAbstract available
ZHANG JT, Dong S, Gu WQ, Zhao N, et al Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non-Small-Cell Lung Cancer
Patients After Radical Resection Based on Longitudinal Undetectable Molecular
Residual Disease: Prospective, Multicenter, Single-Arm Study (CTONG 2201).
Clin Lung Cancer. 2023 Oct 6:S1525-7304(23)00189. PubMedAbstract available
KOBAT H, Elkonaissi I, Foreman E, Davidson M, et al Smoking, Diabetes Mellitus, and Previous Cardiovascular Disease as Predictors of
Anticancer Treatment-Induced Cardiotoxicity in Non-Small-Cell Lung Cancer: A
Real-World Study.
Clin Lung Cancer. 2023 Oct 4:S1525-7304(23)00187. PubMedAbstract available
NAKAMICHI S, Kubota K, Matsuyama K, Misumi T, et al A Phase ? Study of Ubenimex Combined With Pembrolizumab, Nab-Paclitaxel, and
Carboplatin for Previously Untreated Advanced Squamous Non-Small-Cell Lung
Cancer: TORG2241 (UBE-Q).
Clin Lung Cancer. 2023 Oct 4:S1525-7304(23)00186. PubMedAbstract available
September 2023
DESAI A, Smith CJ, Ashara Y, Orme JJ, et al Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for
Extensive Stage Small Cell Lung Cancer.
Clin Lung Cancer. 2023 Sep 17:S1525-7304(23)00183. PubMedAbstract available
TAKADA K, Takamori S, Brunetti L, Crucitti P, et al Impact of Neoadjuvant Immune Checkpoint Inhibitors on Surgery and Perioperative
Complications in Patients With Non-small-cell Lung Cancer: A Systematic Review.
Clin Lung Cancer. 2023 Sep 3:S1525-7304(23)00182. PubMedAbstract available
August 2023
BOCHTLER T, Christopoulos P, Schlamp K, Winkler F, et al Management of a Pregnant ALK-Positive Lung Cancer Patient With Alectinib-Induced
Pneumonitis and Bilateral Globus Pallidus Necrosis Postpartum.
Clin Lung Cancer. 2023 Aug 30:S1525-7304(23)00181. PubMed
BRAMBILLA M, Beninato T, Piemontese A, Mazzeo L, et al Exploring the Role of Immunotherapy-Based Treatments for Advanced Non-Small-Cell
Lung Cancer With Novel Driver Alterations.
Clin Lung Cancer. 2023 Aug 23:S1525-7304(23)00149. PubMedAbstract available
EBADI M, Ladbury C, Liu J, Rock A, et al Stereotactic Body Radiation Therapy for Oligoprogressive and Oligorecurrent
Non-Small-Cell Lung Cancer.
Clin Lung Cancer. 2023 Aug 22:S1525-7304(23)00180. PubMedAbstract available
PETRANOVIC M, McDermott S, Mercaldo S, Little BP, et al Impact of Baseline Interstitial Lung Abnormalities on Pneumonitis Risk in
Patients Receiving Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer.
Clin Lung Cancer. 2023 Aug 21:S1525-7304(23)00179. PubMedAbstract available
HONG YR, Wheeler M, Wang R, Karanth S, et al Patient-Provider Discussion About Lung Cancer Screening by Race and Ethnicity:
Implications for Equitable Uptake of Lung Cancer Screening.
Clin Lung Cancer. 2023 Aug 18:S1525-7304(23)00175. PubMedAbstract available
HASHIMOTO K, Murakami Y, Omura K, Takahashi H, et al Prediction of Tumor PD-L1 Expression in Resectable Non-Small Cell Lung Cancer by
Machine Learning Models Based on Clinical and Radiological Features: Performance
Comparison With Preoperative Biopsy.
Clin Lung Cancer. 2023 Aug 11:S1525-7304(23)00155. PubMedAbstract available